PRE 14A

PROXY STATEMENT

Company: Bluejay Diagnostics, Inc.
Filed: April 5, 2024
Period of Report: April 5, 2024
Accession Number: 0001213900-24-030886

View Document ↗ View on SEC.gov ↗